SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-292016
Filing Date
2022-11-23
Accepted
2022-11-23 16:06:37
Documents
13
Period of Report
2022-11-18
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d410213d8k.htm   iXBRL 8-K 27129
  Complete submission text file 0001193125-22-292016.txt   192225

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cmra-20221118.xsd EX-101.SCH 3900
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmra-20221118_def.xml EX-101.DEF 14483
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmra-20221118_lab.xml EX-101.LAB 24072
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmra-20221118_pre.xml EX-101.PRE 15581
7 EXTRACTED XBRL INSTANCE DOCUMENT d410213d8k_htm.xml XML 5395
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 617.871.2101 EXT 313
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41403 | Film No.: 221416391
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences